Canada Pension Plan Investment Board’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,900
Closed -$96.8K 1800
2025
Q4
$96.8K Sell
3,900
-600
-13% -$12K ﹤0.01% 1816
2025
Q3
$73K Buy
4,500
+1,100
+32% +$15.6K ﹤0.01% 1223
2025
Q2
$44.6K Buy
+3,400
New +$49K ﹤0.01% 1265

Other funds holding EWTX

Canada Pension Plan Investment Board's EWTX Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 3,900 shares — an estimated $96.8K sold.

Canada Pension Plan Investment Board first reported a position in EWTX in Q2 2025 and held it in 3 quarters. The position peaked at $96.8K in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 3,900 Edgewise Therapeutics shares in Q1 2026, an estimated $96.8K.
  • Canada Pension Plan Investment Board first reported a position in Edgewise Therapeutics in Q2 2025 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Edgewise Therapeutics position peaked at $96.8K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.